Category: Prostate Cancer

Less than a third of men with a PSA result in the "gray zone" of 4–10 actually have prostate cancer. Yet for years, that number alone sent patients straight to biopsy. Today, mpMRI offers a smarter first step and a newly FDA-approved blood test called IsoPSA may be the safety net for cases MRI can't fully resolve. keep reading

What do prostate cancer and heart disease share? More than most men realize. Both are fueled by poor lifestyle habits that create a disease-fostering environment in the body — but both can also be fought with the same powerful tool. Research on 802 cancer survivors points to the Mediterranean Diet as a key ally in long-term survival. keep reading

Smoking raises prostate cancer risk by 40–60% — most men know that. But what about the air outside your door? A Canadian study found that two common pollutants, PM2.5 and nitrogen dioxide, are linked to higher PCa risk even in men who've never smoked. And a 2025 European report warns a far broader chemical threat is quietly building. keep reading

Prostate cancer patients benefit from personalized exercise plans, including resistance training, aerobic activity, and high-intensity intervals. Each type of exercise brings unique advantages—supporting strength, cardiovascular health, recovery, and overall well-being. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Evidence shows that lifestyle changes like plant-based eating, regular activity, and stress management can influence prostate cancer outcomes and even affect gene expression. Studies indicate these habits may slow disease progression and offer additional health benefits. keep reading

Focal therapy gives men with localized prostate cancer an appealing option—effective control with fewer side effects. Discover who qualifies for focal treatment, how it compares to radical approaches and Active Surveillance, and why specialized diagnosis is essential. keep reading

Traditional PSA screening can lead to overdetection and unnecessary biopsies due to its lack of specificity for prostate cancer. New research highlights biparametric MRI as a promising, quicker, and potentially more accurate first-line screening tool. keep reading

Dr. Eric Walser brings a unique blend of innovation, compassion, and experience to the Sperling Prostate Center. Learn how his journey from academia to advanced prostate care is making a difference for men seeking the latest in diagnosis and treatment. keep reading

Dr. Eric Walser, a leader in focal ablation for prostate cancer, is now part of the Sperling Prostate Center team. His expertise in interventional radiology and men’s health enhances advanced care and brings new treatments to the Center. keep reading